Glycated albumin blood test for diabetes monitoring
Part of Hormones & metabolism clinical trials.
This study tests a new way to check your blood sugar control using a simple blood test that looks at glycated albumin, which may be more accurate than other tests. It is for people with diabetes who already use a continuous glucose monitor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Have a diabetes diagnosis
- Currently use a continuous glucose monitor (CGM)
- Do not have cirrhosis, nutritional deficiencies, or low blood albumin (hypoalbuminemia)
- Not be pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures “circulating biomarkers” (blood-based signals) in people with type 1 or type 2 diabetes, and in some people without diabetes who test positive for certain diabetes antibodies. The goal is to understand what these blood signals can tell us about diabetes development and progression.
This study tests if using a continuous glucose monitor (a small sensor that checks blood sugar without finger pricks) helps people with type 2 diabetes who are on insulin and have trouble accessing care. It's for patients in the New Orleans area with Medicaid, free care, or no insurance.
This study checks if people with diabetes can safely collect their own blood samples at home for routine check-ups. It aims to make monitoring more convenient.
This study uses a continuous glucose monitor (a small sensor that tracks blood sugar levels) along with a special drink test to find early signs of diabetes. It may help people who are at risk or have early blood sugar problems get a clearer picture of their health.
This study uses a continuous glucose monitor to track blood sugar fluctuations in people with different types of glucose metabolism issues, including those with genetic diabetes or high insulin levels. The goal is to understand how blood sugar varies, which may help improve care.
This study tests a new continuous glucose monitor that checks your blood sugar levels in real time. It aims to see how accurate and safe it is for people with diabetes.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.